Cooper C. Collins, Chief Strategic Officer at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 3,590,000 shares at $3.59 ($12.2M) on 2014-03-04, disclosed to the SEC on 2014-03-05.
Scheduled sale ($12.2M) by Chief Strategic Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.61 | 42,805 | $155K | 1.3% |
| 2 | $3.40 | 3,500,000 | $11.9M | 97.3% |
| 3 | $3.59 | 47,195 | $169K | 1.4% |
| Total | $3.41 avg | 3,590,000 | $12.2M | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |